Epidemiological characteristics of the SARS-CoV-2 Theta variant (P.3) in the Central Visayas region, Philippines, 30 October 2020–16 February 2021

Detalles Bibliográficos
Autores principales: Haw, Nel Jason L., Cañal, Eugenia Mercedes R., Zuasula, Juanito, Loreche, Mary Jean, Bernadas, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2022
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935296/
https://www.ncbi.nlm.nih.gov/pubmed/35355903
http://dx.doi.org/10.5365/wpsar.2022.13.1.883
_version_ 1784672015564668928
author Haw, Nel Jason L.
Cañal, Eugenia Mercedes R.
Zuasula, Juanito
Loreche, Mary Jean
Bernadas, Jaime
author_facet Haw, Nel Jason L.
Cañal, Eugenia Mercedes R.
Zuasula, Juanito
Loreche, Mary Jean
Bernadas, Jaime
author_sort Haw, Nel Jason L.
collection PubMed
description
format Online
Article
Text
id pubmed-8935296
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher World Health Organization
record_format MEDLINE/PubMed
spelling pubmed-89352962022-03-29 Epidemiological characteristics of the SARS-CoV-2 Theta variant (P.3) in the Central Visayas region, Philippines, 30 October 2020–16 February 2021 Haw, Nel Jason L. Cañal, Eugenia Mercedes R. Zuasula, Juanito Loreche, Mary Jean Bernadas, Jaime Western Pac Surveill Response J Covid-19 World Health Organization 2022-02-09 /pmc/articles/PMC8935296/ /pubmed/35355903 http://dx.doi.org/10.5365/wpsar.2022.13.1.883 Text en (c) 2022 The authors; licensee World Health Organization. https://creativecommons.org/licenses/by/3.0/igo/This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode (https://creativecommons.org/licenses/by/3.0/igo/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.
spellingShingle Covid-19
Haw, Nel Jason L.
Cañal, Eugenia Mercedes R.
Zuasula, Juanito
Loreche, Mary Jean
Bernadas, Jaime
Epidemiological characteristics of the SARS-CoV-2 Theta variant (P.3) in the Central Visayas region, Philippines, 30 October 2020–16 February 2021
title Epidemiological characteristics of the SARS-CoV-2 Theta variant (P.3) in the Central Visayas region, Philippines, 30 October 2020–16 February 2021
title_full Epidemiological characteristics of the SARS-CoV-2 Theta variant (P.3) in the Central Visayas region, Philippines, 30 October 2020–16 February 2021
title_fullStr Epidemiological characteristics of the SARS-CoV-2 Theta variant (P.3) in the Central Visayas region, Philippines, 30 October 2020–16 February 2021
title_full_unstemmed Epidemiological characteristics of the SARS-CoV-2 Theta variant (P.3) in the Central Visayas region, Philippines, 30 October 2020–16 February 2021
title_short Epidemiological characteristics of the SARS-CoV-2 Theta variant (P.3) in the Central Visayas region, Philippines, 30 October 2020–16 February 2021
title_sort epidemiological characteristics of the sars-cov-2 theta variant (p.3) in the central visayas region, philippines, 30 october 2020–16 february 2021
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935296/
https://www.ncbi.nlm.nih.gov/pubmed/35355903
http://dx.doi.org/10.5365/wpsar.2022.13.1.883
work_keys_str_mv AT hawneljasonl epidemiologicalcharacteristicsofthesarscov2thetavariantp3inthecentralvisayasregionphilippines30october202016february2021
AT canaleugeniamercedesr epidemiologicalcharacteristicsofthesarscov2thetavariantp3inthecentralvisayasregionphilippines30october202016february2021
AT zuasulajuanito epidemiologicalcharacteristicsofthesarscov2thetavariantp3inthecentralvisayasregionphilippines30october202016february2021
AT lorechemaryjean epidemiologicalcharacteristicsofthesarscov2thetavariantp3inthecentralvisayasregionphilippines30october202016february2021
AT bernadasjaime epidemiologicalcharacteristicsofthesarscov2thetavariantp3inthecentralvisayasregionphilippines30october202016february2021

Ejemplares similares